| thalidomide / Generic mfg. |
NCT00006006: Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed |
|
|
| Completed | 2 | 38 | US | recombinant interferon alfa, thalidomide | National Cancer Institute (NCI) | Liver Cancer | 03/05 | | | |
NCT00058487: Epirubicin and Thalidomide in Treating Patients With Liver Cancer |
|
|
| Completed | 2 | 12 | US | epirubicin hydrochloride, thalidomide | Dana-Farber Cancer Institute, National Cancer Institute (NCI) | Liver Cancer | | 01/07 | | |
NCT00519688: UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma |
|
|
| Completed | 2 | 44 | RoW | Thalidomide, Thado, Tegafur/Uracil, UFUR | National Taiwan University Hospital | Hepatocellular Carcinoma | 08/10 | 08/10 | | |
NCT00971126: Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC) |
|
|
| Terminated | 1/2 | 3 | RoW | sorafenib (Nexavar®), thalidomide (Thado®), Nexavar®), Thado® | National Health Research Institutes, Taiwan, National Cheng-Kung University Hospital, Chang Gung Memorial Hospital | Hepatocellular Carcinoma | 01/10 | 03/10 | | |
